Review findings

BPC-157 Peptide: Complete Research Guide to the Body Protection Compound | Peptide Protocol Wiki Skip to main content 🧬 Peptide Protocol Wiki Peptides Side Effects New Learn Directory Tools Blog News About ⌘K ⌘K 🌱 New to Peptides?

Restore access No thanks, continue reading Related Reading Peptide TB500 thymosin beta-4 healing peptide Peptide GHK-Cu copper peptide for tissue repair Peptide KPV anti-inflammatory peptide How BPC-157 works at the cellular level Overview of BPC-157 benefits and applications Scientific Details Molecular Formula C62H98N16O22 Molecular Weight 1419.53 Da CAS Number 137525-51-0 Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val What Is BPC-157? # BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids (sequence: GEPPPGKPADDAGLV), derived from a protective protein naturally found in human gastric juice.

Restore access No thanks, continue reading Related Reading Peptide TB500 thymosin beta-4 healing peptide Peptide GHK-Cu copper peptide for tissue repair Peptide KPV anti-inflammatory peptide How BPC-157 works at the cellular level Overview of BPC-157 benefits and applications Scientific Details Molecular Formula C62H98N16O22 Molecular Weight 1419.53 Da CAS Number 137525-51-0 Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val What Is BPC-157? # BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids (sequence: GEPPPGKPADDAGLV), derived from a protective protein naturally found in human gastric juice.

Restore access No thanks, continue reading Related Reading Peptide TB500 thymosin beta-4 healing peptide Peptide GHK-Cu copper peptide for tissue repair Peptide KPV anti-inflammatory peptide How BPC-157 works at the cellular level Overview of BPC-157 benefits and applications Scientific Details Molecular Formula C62H98N16O22 Molecular Weight 1419.53 Da CAS Number 137525-51-0 Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val What Is BPC-157? # BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids (sequence: GEPPPGKPADDAGLV), derived from a protective protein naturally found in human gastric juice.

molecular weight of approximately 1,419 Da and the CAS number 137525-51-0, BPC-157 has become one of the most extensively studied peptides in preclinical tissue repair research.

itoneal, oral, topical, intra-articular BPC-157 Mechanism of Action # BPC-157 is a pleiotropic peptide with predominantly endothelial and cytoprotective actions.

e of BPC-157 is its bidirectional normalization of the NO system: BPC-157 counteracts both NOS inhibition (e.g., L-NAME) and NOS overstimulation (e.g., L-arginine), normalizing tissue NO levels while suppressing free radical formation across ischemia/reperfusion and other injury models Effects include protection from thrombosis/arrhythmias and improved perfusion linked to collateral vessel recruitment The Src-Caveolin-1-eNOS signaling pathway is engaged to modulate vasomotor tone and collateral recruitment Cell Migration and Tissue Repair Pathways # BPC-157 activates focal adhesion kinase (FAK) and paxillin, promoting fibroblast outgrowth and migration.

2, AKT, eNOS Angiogenesis activation HUVECs, rodent ischemia models Src-Caveolin-1-eNOS Src kinase, Caveolin-1, eNOS Vasomotor modulation Vascular/ischemia models NO system eNOS/nNOS, tissue NO, ROS Bidirectional normalization L-NAME/L-arginine rodent models FAK-paxillin FAK, paxillin, cytoskeleton Cell migration promotion Tendon fibroblast assays GH receptor GHR expression, JAK2 Receptor sensitization Human tendon fibroblasts in vitro BPC-157 Research by Body System # Gastrointestinal Healing # The gastrointestinal tract is the origin tissue for BPC-157 and the most extensively studied application: Colonic ischemia-reperfusion : Topical BPC-157 (10 mcg/kg) rapidly restored microvascular perfusion in rat models, reducing ischemic pale area from 86% to 10% within 15 minutes, with normalization of tissue malondialdehyde and NO levels (Sikiric P et al.

orted decreases in Disease Activity Index versus placebo, though full results have not been posted publicly (magnitude not quantified in published reports) Tendon and Ligament Repair # BPC-157 has shown consistent effects on connective tissue healing in rodent models: After rat medial collateral ligament transection, BPC-157 restored biomechanical properties toward normal by day 14: breaking force ~34.1 N, elongation ~2.3 mm, absorbed energy ~34.8 N-mm, stiffness ~20.3 N/mm Macroscopic fiber organization normalized and inflammatory markers decreased In vitro, BPC-157 increased tendon fibroblast growth hormone receptor expression, supporting enhanced proliferation when combined with GH (Chang CH et al.

physiological data indicate normalization across dopaminergic, serotonergic, glutamatergic, GABAergic, cholinergic, and adrenergic systems, the absence of direct receptor binding suggests upstream vascular/cytoprotective mechanisms mediate these effects Wound Healing and Skin # In rat alkali-burn models, topical BPC-157 (200-800 ng/mL) accelerated wound closure to 77-82% by day 18 versus 60% in controls, matching or approaching bFGF Histology showed superior granulation, re-epithelialization, collagen deposition, and increased VEGF-A expression In HUVECs, BPC-157 increased proliferation, migration, and tube formation via ERK1/2 signaling Ocular Protection # In rat glaucoma models, BPC-157 given as eye drops, intraperitoneally, or orally immediately normalized intraocular pressure, reversed mydriasis, and preserved retinal ganglion cells, optic nerve thickness, and fundus vessel appearance, both prophylactically and when started 24 hours post-injury.

Both oral and injectable (subcutaneous, intraperitoneal) administration routes have shown efficacy in animal studies: Oral administration : BPC-157 is consistently described as stable in human gastric juice and freely soluble in water at pH 7.0.

Kennedy Jr. announced that approximately 14 of the 19 restricted peptides, including BPC-157, would be reclassified from Category 2 back to Category 1, allowing licensed compounding pharmacies to prepare them with a physician prescription BPC-157 remains unapproved by the FDA for any specific medical indication.

PMID 25897838) 3 BPC-157 Evidence Gaps and Limitations # The current evidence base for BPC-157 has important limitations that should inform interpretation: Concentration of authorship : Many preclinical findings originate from overlapping research groups, with limited independent replication No completed Phase 2/3 trials : Human efficacy remains unconfirmed by robust, publicly posted randomized trials Uncertain pharmacokinetics : Human studies frequently report plasma levels below quantification limits after oral and rectal dosing Publication venue concerns : Several comprehensive reviews and primary reports appear

PMID: 25897838): Reduced bleeding time Improved platelet function Potential hemostatic effects References # Related Reading # BPC-157 molecular structure and properties BPC-157 research studies and evidence BPC-157 dosing protocols BPC-157 side effects profile BPC-157 risks and safety considerations Similar peptides to BPC-157 T

PMID: 25897838. ↩ Stay current on BPC-157 research We summarize new studies, safety updates, and dosing insights — delivered biweekly.

B-500 research guide -- Thymosin beta-4 fragment for tissue repair GHK-Cu research guide -- Copper peptide for wound healing Alprostadil research guide -- Prostaglandin for vascular healing ARA-290 research guide -- Cytoprotective peptide Footnotes # Sikiric P, Seiwerth S, Rucman R, et al.

How long does BPC-157 take to work?

Is BPC-157 FDA approved?

Report an Error Compare BPC-157 with Other Peptides BPC-157 vs GHK-Cu BPC-157 for deep tissue, GI, and musculoskeletal healing research;

Healing & Tissue Repair Anti-Aging & Longevity Skin & Hair GHK-Cu GHK-Cu: Copper tripeptide for skin healing and anti-aging.

BPC-157 is a preclinical research peptide studied for tissue healing without any human clinical trials.

For general gut healing, tissue repair, or conditions outside SBS, BPC-157 offers preclinical promise but lacks the clinical evidence to support definitive recommendations. → BPC-157 vs Ziconotide BPC-157 and ziconotide serve fundamentally different purposes and represent opposite ends of the evidence spectrum.

Peptide Protocol Wiki June 4, 2026 Retatrutide BPC-157 Tesamorelin + 6 more Guide 12 min read Core Peptides Review 2026: COAs, Finnrick Controversy, and Whether the Score Holds Up An honest 2026 review of Core Peptides covering product range, payment flexibility, shipping, COA transparency, and how the Finnrick Analytics controversy should change how you read vendor ratings.

Peptide Protocol Wiki June 4, 2026 Retatrutide BPC-157 Tesamorelin + 6 more Guide 12 min read Core Peptides Review 2026: COAs, Finnrick Controversy, and Whether the Score Holds Up An honest 2026 review of Core Peptides covering product range, payment flexibility, shipping, COA transparency, and how the Finnrick Analytics controversy should change how you read vendor ratings.

Peptide Protocol Wiki June 3, 2026 Semaglutide Tirzepatide Retatrutide + 1 more You Might Also Like Related content you may find interesting Peptide Healing GHK-Cu Peptide Healing TB500 Peptide Healing Teduglutide Peptide Metabolic Semaglutide Table of Contents What Is BPC-157?

asis BPC-157 Research by Body System Gastrointestinal Healing Tendon and Ligament Repair Neurological and Spinal Cord Injury Wound Healing and Skin Ocular Protection Additional Applications BPC-157 Oral vs Injectable Research BPC-157 Regulatory Status (2026 Update) BPC-157 Clinical Evidence and Safety Human Studies Safety Profile BPC-157 Evidence Gaps and Limitations Key Research Findings References Related Reading Research Briefing Biweekly peptide updates backed by published studies.

Browse all healing peptides → Table of Contents 📌 TL;DR • Promotes angiogenesis through VEGFR2-Akt-eNOS axis activation in preclinical models • Demonstrates gastrointestinal protective and healing effects across multiple animal models • Accelerates tendon, ligament, and musculoskeletal repair in rodent studies • Modulates nitric oxide signaling bidirectionally, normalizing both NOS inhibition and overstimulation • Shows stability in gastric acid, supporting oral administration research • Generally well-tolerated in animal studies and limited human safety data Community-Reported Side Effects Anecdotal ? 📋 Protocol Quick-Reference Tissue healing and injury recovery 💉 Dosing Amount 250-500 mcg Frequency Twice daily (morning and evening) Duration 4-6 weeks 💊 Administration Route SC Schedule Twice daily (morning and evening) Timing Morning and evening, approximately 12 hours apart; can be injected near injury site for localized effect 📅 Cycle Duration 4-6 weeks Repeatable Yes Preparation & Storage Diluent: Bacteriostatic water Storage: Lyophilized powder: Store at -20°C.

dose: 500 mcg · cycle: Cycle · route: oral · timing: morning · frequency: Twice daily · reconstitution: Bacteriostatic

Injectable administration : Subcutaneous and intraperitoneal routes have been the most common in animal studies, with doses typically ranging from 10 ng/kg to 10 mcg/kg.

dose: 10 mcg · route: Subcutaneous

BPC-157 Clinical Evidence and Safety # Human Studies # The human evidence base for BPC-157 remains limited: Phase 1 oral safety/PK (NCT02637284) : 42 healthy volunteers received oral BPC-157 at 1-9 mg/day for up to two weeks.

dose: 9 mg · route: oral

ive colitis RCT : Multicenter, randomized, double-blind, placebo-controlled trial (n=53) using 80 mg enema daily for two weeks.

dose: 80 mg · frequency: daily

2, AKT, eNOS Angiogenesis activation HUVECs, rodent ischemia models Src-Caveolin-1-eNOS Src kinase, Caveolin-1, eNOS Vasomotor modulation Vascular/ischemia models NO system eNOS/nNOS, tissue NO, ROS Bidirectional normalization L-NAME/L-arginine rodent models FAK-paxillin FAK, paxillin, cytoskeleton Cell migration promotion Tendon fibroblast assays GH receptor GHR expression, JAK2 Receptor sensitization Human tendon fibroblasts in vitro BPC-157 Research by Body System # Gastrointestinal Healing # The gastrointestinal tract is the origin tissue for BPC-157 and the most extensively studied application: Colonic ischemia-reperfusion : Topical BPC-157 (10 mcg/kg) rapidly restored microvascular perfusion in rat models, reducing ischemic pale area from 86% to 10% within 15 minutes, with normalization of tissue malondialdehyde and NO levels (Sikiric P et al.

dose: 10 mcg · route: Topical

PMID 24304574) 1 Ulcerative colitis : A small multicenter RCT (n=53) using 80 mg BPC-157 enema daily for two weeks rep

dose: 80 mg · frequency: daily

Animal studies have used oral doses (typically 10 mcg/kg in drinking water at 0.16 mcg/mL) with reported therapeutic effects across GI, musculoskeletal, and other models.

dose: 10 mcg · route: oral

PMID 25415472) 2 A 2025 systematic review of 36 studies (35 preclinical, 1 clinical) confirmed consistent improvement in functional, structural, and biomechanical outcomes across muscle, tendon, ligament, and bony injury models Neurological and Spinal Cord Injury # In rat spinal cord compression, a single dose of BPC-157 (2 or 200 mcg/kg) 10 minutes post-injury produced consistent functional recovery: improved tail motor scores, resolved spasticity by day 15, and prevented autotomy Histology showed markedly fewer vacuoles and necrosis in white and gray matter BPC-157 counteracted cuprizone-induced brain demyelination and motor disability in rodent models (Sikiric P et al.

dose: 200 mcg

review of the peptides most often discussed alongside retatrutide for GI side effects, lean-mass preservation, hair and skin changes, sleep, and adjunct fat loss — what the literature does and does not support.

BPC-157 Peptide: Complete Research Guide to the Body Protection Compound | Peptide Protocol Wiki Skip to main content 🧬 Peptide Protocol Wiki Peptides Side Effects New Learn Directory Tools Blog News About ⌘K ⌘K 🌱 New to Peptides?

Start the 7-step beginner guide Peptides Side Effects New Directory Learn Tools Blog News About BPC-157 📋 Overview 🧬 Molecule 🔄 Similar ⚠️ Side Effects 💉 Dosing 🔬 Research 🚨 Risks 👥 Community 📊 Community Data Home Peptides BPC-157 Healing & Tissue Repair Brain & Neuroprotection preclinical BPC-157 Also known as: Body Protection Compound-157, Pentadecapeptide BPC 157, PL-14736, Bepecin Compare with 5 peptide s Research compiled by Peptide Protocol Wiki 📅 Updated March 7, 2026 Citations verified: January 10, 2024 Citations Verified January 10, 2024 TL;DR BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a protective protein found in human gastric juice.

Covers mechanism, Caverject/MUSE delivery, clinical data, dosing, and side effects.

Browse all healing peptides → Table of Contents 📌 TL;DR • Promotes angiogenesis through VEGFR2-Akt-eNOS axis activation in preclinical models • Demonstrates gastrointestinal protective and healing effects across multiple animal models • Accelerates tendon, ligament, and musculoskeletal repair in rodent studies • Modulates nitric oxide signaling bidirectionally, normalizing both NOS inhibition and overstimulation • Shows stability in gastric acid, supporting oral administration research • Generally well-tolerated in animal studies and limited human safety data Community-Reported Side Effects Anecdotal ? 📋 Protocol Quick-Reference Tissue healing and injury recovery 💉 Dosing Amount 250-500 mcg Frequency Twice daily (morning and evening) Duration 4-6 weeks 💊 Administration Route SC Schedule Twice daily (morning and evening) Timing Morning and evening, approximately 12 hours apart; can be injected near injury site for localized effect 📅 Cycle Duration 4-6 weeks Repeatable Yes Preparation & Storage Diluent: Bacteriostatic water Storage: Lyophilized powder: Store at -20°C.

Safety Profile # Animal toxicology summaries claim high acute tolerability (LD50 not reached at high doses) No serious adverse effects reported at standard research doses in animal studies Human safety assertions rely on small early-phase studies and anecdotal reports without systematic pharmacovigilance Standard coagulation parameters remain unaffected despite platelet function modulation (Stupnisek M et al.

Covers actin regulation, wound healing, cardioprotective research, dosing, and side effects. ⚠️ Medical Disclaimer This website is for educational and informational purposes only.

in lower-quality journals Methodological variability : Small sample sizes, inconsistent endpoints, and limited adverse-event reporting across preclinical studies Translation uncertainty : Extensive rodent evidence may not directly translate to human clinical outcomes Key Research Findings # Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in human tendon fibroblasts , published in Molecules (Chang CH et al., 2014;

Ziconotide is an FDA-approved medication with rigorous clinical trial data, but it is reserved for severe refractory pain requiring intrathecal delivery and carries significant CNS side effects.

Peptide Directory All Peptides Metabolic Anti-Obesity Anti-Aging Immune Hormonal View All Categories Directory Peptide Vendors Analytics Labs Side Effects Database Report a Side Effect Learn Start Here What Are Peptides?

PMID: 25897838): Reduced bleeding time Improved platelet function Potential hemostatic effects References # Related Reading # BPC-157 molecular structure and properties BPC-157 research studies and evidence BPC-157 dosing protocols BPC-157 side effects profile BPC-157 risks and safety considerations Similar peptides to BPC-157 T

BPC-157 has shown a favorable safety profile in animal studies with no reported serious adverse effects at standard research doses.

bolic Panel) When: Baseline Why: Liver and kidney function baseline CBC When: 4 weeks Why: Monitor for any changes CMP When: 4 weeks Why: Monitor liver and kidney function Liver enzymes (ALT, AST) When: Ongoing Why: Elevation above 3x upper limit of normal ⚠️ Elevation above 3x upper limit of normal 💡 Key Considerations → Can be injected near the site of injury for localized effect → No fasting required → Contraindication: Avoid in active cancer or pregnancy due to angiogenic potential; not approved for human use Subscribe to unlock this content Get weekly peptide research summaries, new study alerts, and protocol updates — free.

bolic Panel) When: Baseline Why: Liver and kidney function baseline CBC When: 4 weeks Why: Monitor for any changes CMP When: 4 weeks Why: Monitor liver and kidney function Liver enzymes (ALT, AST) When: Ongoing Why: Elevation above 3x upper limit of normal ⚠️ Elevation above 3x upper limit of normal 💡 Key Considerations → Can be injected near the site of injury for localized effect → No fasting required → Contraindication: Avoid in active cancer or pregnancy due to angiogenic potential; not approved for human use Subscribe to unlock this content Get weekly peptide research summaries, new study alerts, and protocol updates — free.

Restore access No thanks, continue reading Related Reading Peptide TB500 thymosin beta-4 healing peptide Peptide GHK-Cu copper peptide for tissue repair Peptide KPV anti-inflammatory peptide How BPC-157 works at the cellular level Overview of BPC-157 benefits and applications Scientific Details Molecular Formula C62H98N16O22 Molecular Weight 1419.53 Da CAS Number 137525-51-0 Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val What Is BPC-157? # BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids (sequence: GEPPPGKPADDAGLV), derived from a protective protein naturally found in human gastric juice.

Peptide Protocol Wiki June 4, 2026 Retatrutide BPC-157 Tesamorelin + 6 more Guide 12 min read Core Peptides Review 2026: COAs, Finnrick Controversy, and Whether the Score Holds Up An honest 2026 review of Core Peptides covering product range, payment flexibility, shipping, COA transparency, and how the Finnrick Analytics controversy should change how you read vendor ratings.

Restore access No thanks, continue reading Related Reading Peptide TB500 thymosin beta-4 healing peptide Peptide GHK-Cu copper peptide for tissue repair Peptide KPV anti-inflammatory peptide How BPC-157 works at the cellular level Overview of BPC-157 benefits and applications Scientific Details Molecular Formula C62H98N16O22 Molecular Weight 1419.53 Da CAS Number 137525-51-0 Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val What Is BPC-157? # BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids (sequence: GEPPPGKPADDAGLV), derived from a protective protein naturally found in human gastric juice.

GHK-Cu for skin rejuvenation, wound healing, and accessible topical applications → BPC-157 vs Semaglutide These peptides serve entirely different purposes and are not interchangeable.

Restore access No thanks, continue reading Related Reading Peptide TB500 thymosin beta-4 healing peptide Peptide GHK-Cu copper peptide for tissue repair Peptide KPV anti-inflammatory peptide How BPC-157 works at the cellular level Overview of BPC-157 benefits and applications Scientific Details Molecular Formula C62H98N16O22 Molecular Weight 1419.53 Da CAS Number 137525-51-0 Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val What Is BPC-157? # BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids (sequence: GEPPPGKPADDAGLV), derived from a protective protein naturally found in human gastric juice.

Report an Error Compare BPC-157 with Other Peptides BPC-157 vs GHK-Cu BPC-157 for deep tissue, GI, and musculoskeletal healing research;

Peptide Protocol Wiki June 3, 2026 Semaglutide Tirzepatide Retatrutide + 1 more You Might Also Like Related content you may find interesting Peptide Healing GHK-Cu Peptide Healing TB500 Peptide Healing Teduglutide Peptide Metabolic Semaglutide Table of Contents What Is BPC-157?